References
1.World Health Organization Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection, updated version. April 2016.
2. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Geneva, Switzerland. 2016.
3.WHO. Global Hepatitis Report 2017. Geneva, Switzerland: World Health Organization; 2017.
4. Document of the General Assembly of the United Nations.
http://www.un.org/ga/search/view_doc.asp?symbol=A/70/L.1&Lang=S
5. Berenguer J. Elimination of hepatitis C virus in Spain: A pending challenge. Enferm Infecc Microbiol Clin. 2018;36(6):323–324.
6. Ministerio de Sanidad, Servicios Sociales e Igualdad (Internet). Informe anual del Sistema Nacional de Salud, 2015;
http://www.msssi.gob.es/estadEstudios/estadisticas/sisInfSanSNS/tablasEstadisticas/Inf_Anual_SNS_2015.1.pdf
7. Aguinaga A, Díaz-González J, Alejandra Pérez-García A, et al. Estimación de la prevalencia de infección diagnosticada y no diagnosticada por el virus de la hepatitis C en Navarra, 2014-2016. Enferm Infecc Microbiol Clin. 2017. http://dx.doi.org/10.1016/j.eimc.2016.12.008
8. I Encuesta De Seroprevalencia De La Comunidad Autónoma Del País Vasco. Departamento de Sanidad y Consumo. Vitoria-Gasteiz, 2011.
9. Gómez-Escolar Viejo, García Herola A, Sáez Lloret I, et al. Screening of hepatitis C virus infection in adult general population in Spain. Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1077-1081. doi: 10.1097/MEG.0000000000001190.
10. Cuadrado A, Perelló C, Llerena S, Gomez M, Escudero MD, Rodriguez L, et al. Estudio de la prevalencia de la hepatitis C en la población española. EstudioPrevHep/Cohorte Ethon. Madrid: 42 Congreso Anual AEEH; 2017.
11. A.M. Hill, A. Khan, B. Simmons, M. Riveiro-Barciela, M. Buti. La Hepatitis C no se eliminará de España en 2030 si no se modifican las estrategias de cribado. Madrid: 43º Congreso Anual AEEH; 2018.
12. Ministerio de Sanidad, Servicios Sociales e Igualdad. Plan estratégico para el abordaje de la hepatitis C en el Sistema Nacional de Salud. Madrid, 21 de mayo de 2015: http://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/hepatitisC/PlanEstrategicoHEPATITISC/docs/plan_estrategico_hepatitis_C.pdf
13. Mohd Hanafiah K7.-Groeger J, Flaxman AD. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.
14. Guidelines on hepatitis B and C testing - Policy brief. Geneva: World Health Organization; Nov 2016
15. Global Health Sector Strategy on Viral Hepatitis (2016–2021). Towards Ending Viral Hepatitis: World Health Organization; Jun 2016.
16. National Hepatitis C Strategy 2011-2014 (Ireland) ISBN 978-1-906218-58-4
17. National Institute for Health and Care Excellence. Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection. NICE, 2012. http://guidance.nice.org.uk/PH43.
18. National Institute for Health and Care Excellence. Hepatitis B and C testing: people at risk of infection. Public health guideline. Published: 12 December,2012. nice.org.uk/guidance/ph43
19. SIGN 133: Management of hepatitis C. A national clinical guideline July 2013. Healthcare Improvement Scotland (HIS). ISBN 978 1 909103 13 9
20. National Health Service: NHS Guidance on Testing, Diagnosis and Referral Of Bloodborne Viruses Version 1.0 April 2013. http://library.nhsggc.org.uk/mediaAssets/PHPU/NHSGGC%20BBV%20Testing%20Guidance.pdf
21 Canadian Task Force on Preventive Health Care: Recommendations on hepatitis C screening for adults. CMAJ 2017 April 24;189:E594-604. doi: 10.1503/cmaj.161521. http://www.cmaj.ca/content/189/16/E594.full.pdf+html
22. Canadian Task Force on Preventive Health Care: Recommendations on hepatitis C screening for adults. https://canadiantaskforce.ca/wp-content/uploads/2017/04/CTFPHC_Hepatitis-C_Clinician-FAQ_v10_FINAL-1.pdf
23. Instituto Nacional de Estadística (INE). (Consulted: 03/11/2017).
http://www.ine.es/dynt3/inebase/es/index.htm?type=pcaxis&file=pcaxis&path=%2Ft20%2Fe245%2Fp04%2F%2Fa201624. European Centre for Disease Prevention and Control. Epidemiological assessment of hepatitis B and C among migrants in the EU/EEA. Stockholm: ECDC; 2016
25. Gower E, Estes C, Blach S, Razavi-Shearer K, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1):S45-S57.
26. http://www.diva-gis.org/.
27. WHO: Guidelines on hepatitis B and C testing. Geneva, Switzerland: World Health Organization; (Nov 2016)
28. Lazarus JV, Wiktor S, Colombo M, Thursz M, on behalf of the EASL International Liver Foundation. Micro-elimination – A path to global elimination of hepatitis C Journal of Hepatology,. vol. 67 j 665–666.(2017)
29. Zuccaro O, Tosti ME, Mele A, Spada E and SEIEVA Collaborative Group. Epidemiology of acute viral hepatitis in Italy: Results of the surveillance through SEIEVA (Sistema Epidemiologico Integrato dell’Epatite Virale Acuta). Roma: Istituto Superiore di Sanità; 2012. (Rapporti ISTISAN 12/4).
30. Marascio et al.: Update on epidemiology of HCV in Italy: focus on the Calabria Region. BMC Infectious Diseases, 14(Suppl 5):S2, (2014)
31. Buonfrate Dora, Gobbi Federico, Marchese Valentina, Postiglione Chiara, Badona Monteiro Geraldo, Giorli Giovanni, Napoletano Giuseppina, Bisoffi Zeno. Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015. Euro Surveill. 2018; 23(16):pii=17-00527. https://doi.org/10.2807/1560-7917.ES.2018.23.16.17-00527
32. Manzardo C Treviño B, Gómez i Prat J, Cabezos J, Mongua E, I Claverıa, Del Vala JL Zabaletab E, Zarzuela,F, Navarroa R Communicable diseases in the immigrant population attended to in a tropical medicine unit: Epidemiological aspects and public health issues. Travel Medicine and Infectious Disease (2008) 6, 4–11
33. Rivas, P*, Herrero M., Poveda E, Madejón A., Treviño A., Gutiérrez M., Ladrón de Guevara C, Lago M, de Mendoza C, Soriano V, Puente S. Hepatitis B, C, and D and HIV Infections among Immigrants from Equatorial Guinea Living in Spain. Am. J. Trop. Med. Hyg., 88(4), 2013, pp. 789–794
34. Monge-Maillo,B* Rogelio Lopez-Velez,R Francesca Norman F, Ferrere-González, F Martínez-Perez, A, Pérez-Molina, JA. Screening of Imported Infectious Diseases among Asymptomatic Sub-Saharan African and Latin American Immigrants: A Public Health Challenge. Am. J. Trop. Med. Hyg., 92(4), 2015, pp. 848–856
35. IV Encuesta De Serovigilancia De La Comunidad De Madrid. Subdirección De Promoción De La Salud Y Prevención. Dirección General de Atención Primaria, 2015
36. Lazarus JV, Bromberg DJ, Del Amo J, Norgaard O, García-Samaniego J, Casellas A, Calleja JL, Requena-Méndez A. Hepatitis C prevalence among the immigrant population in Spain: A systematic review and meta-analysis. Enferm Infecc Microbiol Clin. May 11. (2018)
37. Mena A, Moldes L, Meijide H, Cañizares A, Castro-Iglesias A , et al. (2014) Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing. PloS ONE 9(12): e113062. doi:10.1371/journal.pone. 0113062
38. Regidor E, Sanz B, Pascual C, Lostao L, Sanchez E y Diaz JM. La utilización de los servicios sanitarios por la población inmigrante en España. Gac Sanit.2009;23(Supl 1):4–11.
39.Hacker, K., Anies, M., Folb, B. L., & Zallman, L. (2015). Barriers to health care for undocumented immigrants: a literature review.Risk Management and Healthcare Policy,8, 175–183. http://doi.org/10.2147/RMHP.S70173